JeanPierre BSc - KDA Chief Officer
KDA Stock | CAD 0.27 0.01 3.85% |
Insider
JeanPierre BSc is Chief Officer of KDA Group
Address | 1351, Notre Dame St. East, Thetford Mines, QC, Canada, G6G 0G5 |
Phone | 418-755-0821 |
Web | https://groupekda.ca |
KDA Management Efficiency
The company has return on total asset (ROA) of (0.1156) % which means that it has lost $0.1156 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.1593) %, meaning that it generated substantial loss on money invested by shareholders. KDA's management efficiency ratios could be used to measure how well KDA manages its routine affairs as well as how well it operates its assets and liabilities. At this time, KDA's Intangible Assets are fairly stable compared to the past year. Other Assets is likely to climb to about 9 M in 2024, whereas Net Tangible Assets are likely to drop (11 M) in 2024.Similar Executives
Showing other executives | INSIDER Age | ||
Lisa PEng | Reliq Health Technologies | N/A | |
Daniel Leon | Leons Furniture Limited | N/A | |
Glenn Brandt | Rogers Communications | N/A | |
Pang Wong | Advent Wireless | 70 | |
Paulina Molnar | Rogers Communications | N/A | |
Joyce MD | Reliq Health Technologies | N/A | |
FCA FCA | Rogers Communications | 57 | |
Lisa Durocher | Rogers Communications | 57 | |
Francis Mak | Advent Wireless | N/A | |
Chris Ryan | Reliq Health Technologies | N/A | |
Dave McKay | Reliq Health Technologies | N/A | |
Jay CA | Dream Office Real | N/A | |
Gordon Wadley | Dream Office Real | N/A | |
John McCulloch | DRI Healthcare Trust | N/A | |
Michael CFA | Reliq Health Technologies | N/A | |
Michael Cooper | Dream Office Real | 63 | |
Ronald McKenzie | Rogers Communications | N/A | |
Behzad CPA | DRI Healthcare Trust | N/A | |
David Levine | DRI Healthcare Trust | N/A | |
Navin Jacob | DRI Healthcare Trust | ||
Faith Bowen | DRI Healthcare Trust | N/A |
Management Performance
Return On Equity | -0.16 | ||||
Return On Asset | -0.12 |
KDA Group Leadership Team
Elected by the shareholders, the KDA's board of directors comprises two types of representatives: KDA inside directors who are chosen from within the company, and outside directors, selected externally and held independent of KDA. The board's role is to monitor KDA's management team and ensure that shareholders' interests are well served. KDA's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, KDA's outside directors are responsible for providing unbiased perspectives on the board's policies.
Stuart Elman, Director | ||
Giuseppe DAprano, Chief Officer | ||
MarieHelene Pinard, Operating Inc | ||
Luc Olivier, Chief Officer | ||
Yves Marmet, Member inc | ||
JeanMarc Leveille, Member Planning | ||
Marc Lemieux, President, Chief Executive Officer | ||
Patrick Fernet, Director | ||
Michael Kinley, Director | ||
JeanPierre BSc, Chief Officer | ||
Annie Mercier, Finance Director | ||
Isabelle Begin, Chief Operating Officer, Executive Vice President - Pharmacy Services Division and Director | ||
Sheldon Elman, Director | ||
Pierre Monet, Secretary |
KDA Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is KDA a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -0.16 | ||||
Return On Asset | -0.12 | ||||
Profit Margin | 54.14 % | ||||
Operating Margin | (55.43) % | ||||
Current Valuation | 46.55 M | ||||
Shares Outstanding | 175.5 M | ||||
Shares Owned By Insiders | 25.48 % | ||||
Number Of Shares Shorted | 1.5 K | ||||
Price To Book | 3.79 X | ||||
Price To Sales | 232.12 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for KDA Stock Analysis
When running KDA's price analysis, check to measure KDA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy KDA is operating at the current time. Most of KDA's value examination focuses on studying past and present price action to predict the probability of KDA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move KDA's price. Additionally, you may evaluate how the addition of KDA to your portfolios can decrease your overall portfolio volatility.